kras mutation and glutathion Frontiers The KRAS-G12D mutation induces metabolic
The KRAS G12D mutation induces metabolic vulnerability in B cell acute lymphoblastic leukemia ScienceDirect KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell Impact of KRAS mutation on the tumor microenvironment in colorectal cancer
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



